. . . . . . . . . . . . "[Overall, these studies have paved the way for the commercial development of PTP1B inhibitors that may serve as a novel type of insulin sensitizer in the management of type 2 diabetes and the cardiovascular / metabolic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2016-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2016-05-13T12:44:36+02:00"^^ . . . . . . . . . . . "v4.0.0.0" . "v4.0.0" .